At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Lung Cancer Screening Invitation Intervention (other), Abdominal scan intervention (diagnostic test)
- How long the study runs
- Study runs about 23 months (dates as stated)
- About the drug or intervention
- Lung Cancer Screening Invitation Intervention — other: Participants are invited to the NHS Lung Cancer Screening to assess lung cancer risk via letter or text message · Abdominal scan intervention — diagnostic test: Receiving an abdominal CT scan at the same time as the lung scan.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 55 Years to 70 Years
- Who
- All
- Number of participants
- 6,272
- Started
- 2025-11-11
- Last checked
- 2025-12
Plain English Summary
What is this study?
- • Testing a new treatment for renal cell carcinoma (kidney cancer)
- • NA - 6,272 participants
- • Early detection through screening can improve cancer survival by identifying it when it's most treatable
Who can take part?
- • Ages 55 Years to 70 Years
- • Diagnosed with renal cell carcinoma (kidney cancer)
Where?
- • Hull - Hull Teaching Hospitals Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Early detection through screening can improve cancer survival by identifying it when it's most treatable. The NHS now offers Lung Cancer Screening (LCS) assessments to people aged 55-74 who have ever smoked. Those at higher risk of lung cancer are offered a lung scan. This group also has a high risk of developing abdominal cancers, such as kidney cancer. A recent study explored whether it would be feasible to extend the lung scan to include the abdomen. Results showed most participants supported this addition, and the number of serious findings was similar to those detected in UK breast or bowel cancer screening programmes. However, the abdominal scan was only offered on the day of the lung scan, giving little time for people to consider their decision. The process also added too much time to be practical for widespread implementation. This new study will: * Test whether mentioning the possible abdominal scan in the initial LCS invitation affects participation in LCS assessments. * Test new processes to assess if the abdominal scan can be added to the lung scan with minimal extra time. * Check if participants can be split between the lung scan only group and lung and abdominal scan group using an approach called 'cluster randomisation'. This will be important in case a bigger trial is needed. * See whether the additional processes are acceptable People aged 55-70 who are invited to the lung cancer screening will be eligible to take part in this study. Only those who are found to be at a high risk of lung cancer after their assessment, and therefore offered a lung scan, will be offered the abdominal scan, provided they have not had an abdominal scan in the previous 12 months or one booked in the next 3 months. This study will take place in two existing lung cancer screening locations in Yorkshire.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 55 Years - 70 Years
- Who can join: All genders
What the study is looking for
- ✓Be registered with a GP in England.
- ✓Be aged 55-70 years 364 days old at the date of invitation.
- ✓Exclusion criteria
- ✓Eligibility criteria for the cluster level randomisation to scan intervention or scan control
- ✓Inclusion criteria a): To be eligible for the cluster level randomisation the participant must:
Who cannot take part
- ✗Participant does not have capacity to give consent (standard criteria for assessing capacity apply).
- ✗Weight or physical size exceeds restrictions for scanner (\>200kg).
- ✗Participant unable to lie flat.
- ✗Poor physical fitness such that treatment with curative intent would be contra-indicated.
- ✗Additional TACTICAL1 exclusion criteria:
See the full criteria
Where Is This Study? (1 UK site)
Hull Teaching Hospitals Trust
Hull HU3 2JZ, United Kingdom
How to Get in Touch
Grant Stewart
Sponsor contactCONTACT
Jessica Kitt
Sponsor contactCONTACT
